Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-01-05 @ 5:20 PM
Study NCT ID:
NCT03532295
Status:
COMPLETED
Last Update Posted:
2025-11-21
First Post:
2018-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Sponsor:
Washington University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-09
First Submit QC Date:
None
Study First Post Date:
2018-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-11
Results First Submit QC Date:
None
Results First Post Date:
2025-08-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-07
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED